FEEDS
Takeda Receives Positive CHMP Opinion in Europe for Edarbi(TM) (azilsartan medoxomil) for the Treatment of Essential Hypertension
London and Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for ... weiter zur Meldung von Takeda Pharmaceuticals Europe Ltd
Takeda Responds to FDA Advisory Committee Recommendation
London, July 15, 2010 (ots/PRNewswire) - The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing ... weiter zur Meldung von Takeda Pharmaceuticals Europe Ltd
